295349-76-7

Downstream Products

• 258503-85-4 N-(4-methyl-3-nitrophenyl)-2-morpholinopyridine-4-carboxamide 
• 687995-79-5 acetic acid 7-methoxy-4-{2-methyl-5-[(2-morpholin-4-yl-pyridine-4-carbonyl)-amino]-phenylamino}-quinazolin-6-yl ester 
• 263400-18-6 6-hydroxy-7-methoxy-4-[2-methyl-5-(2-morpholinopyridine-4-carboxamido)anilino]quinazoline 

Relevant academic research and scientific papers

Amide derivatives

The invention concerns amide derivatives of the Formula I wherein X is CH or N; Y is CH or N; m is 0-3; R1is a group such as hydroxy, halogeno, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy and carbamoyl; n is 0-3; R2is a group such as hydroxy, halogeno, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy and (1-6C)alkoxycarbonyl; R3is hydrogen, halogeno, (1-6C)alkyl or (1-6C)alkoxy; q is 0-4; and Q is a group such as aryl, aryloxy, aryl-(1-6C)alkoxy, arylamino,N-(1-6C)alkyl-arylamino and aryl-(1-6C)alkylamino; or pharmaceutically-acceptable salts or in-vivo-cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.